PRMT5 Inhibition Drives Therapeutic Vulnerability to Combination Treatment with BCL-2 Inhibition in Mantle Cell Lymphoma.
Fiona Brown-Burke,Inah Hwang,Shelby Sloan,Claire Hinterschied,Jobeth Helmig-Mason,Mackenzie Long,Wing Keung Chan,Alexander Prouty,Ji-Hyun Chung,Yang Zhang,Satishkumar Singh,Youssef,Neha Bhagwat,Zhengming Chen,Selina Chen-Kiang,Maurizio Di Liberto,Olivier Elemento,Lalit Sehgal,Lapo Alinari,Kris Vaddi,Peggy Scherle,Rosa Lapalombella,Jihye Paik,Robert A. Baiocchi BLOOD ADVANCES（2023）
AI 理解论文
溯源树
样例
